Brief cognitive behavioral therapy appears promising for head and neck cancer survivors with body-image distress

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cedars-Sinai performed the first robot-assisted microsurgical head-and-neck cancer reconstructive surgery in the United States after the robot device received FDA approval for the procedure.

February 21, 2025

Vol.51 No.07

Podcast

In The Headlines: Kimryn Rathmell on loss and caring for our community in uncertain times

In this episode of In the Headlines, former NCI Director Kimryn Rathmell speaks with Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, about the HHS layoffs and their potential impact on mental health. These layoffs—and the broader uncertainty introduced by the current administration’s actions—are a form of trauma, Rathmell says.

February 19, 2025

Vol.51 No.06

Guest Editorial

Preparing to take care of each other in ways we never imagined

Being summarily dismissed, denigrated, and divided is both dehumanizing and taking place in a radical and disorienting manner. The effect is traumatizing.

February 14, 2025

Vol.51 No.06

By W. Kimryn Rathmell

Clinical Roundup

Nivolumab demonstrates superiority over standard of care for head-and-neck cancer in phase III trial

The Groupe d’Oncologie Radiothérapie Tête Et Cou, also known as the Head and Neck Oncology and Radiotherapy Group or GORTEC, announced that the randomized phase III CheckMate -9KW/NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab (Opdivo) as a post-operative treatment component for resected patients with locally advanced squamous cell carcinoma of head and neck with high risk of relapse met its primary endpoint of disease-free survival across all comers.

January 17, 2025

Vol.51 No.02

Clinical Roundup

Psychedelic drug therapy may address mental health concerns in people with cancer and addiction

One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests. A second new study found that treatment with psilocybin resulted in lasting, positive personality changes in patients with alcohol use disorder.

January 10, 2025

Vol.51 No.01

In Brief

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

LSU Health New Orleans was awarded a five-year, $3.1 million grant from the National Institute of Dental and Craniofacial Research.

November 15, 2024

Vol.50 No.43

Brief cognitive behavioral therapy appears promising for head and neck cancer survivors with body-image distress

YOU MAY BE INTERESTED IN

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

In The Headlines: Kimryn Rathmell on loss and caring for our community in uncertain times

Preparing to take care of each other in ways we never imagined

Nivolumab demonstrates superiority over standard of care for head-and-neck cancer in phase III trial

Psychedelic drug therapy may address mental health concerns in people with cancer and addiction

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

Renew today!

Subscriber content

Never miss an issue!

Login